Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
7.91
+0.06 (0.76%)
Jul 3, 2025, 1:00 PM - Market closed
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $126.42 million as of July 3, 2025. Its market cap has increased by 55.06% in one year.
Market Cap
126.42M
Enterprise Value
113.86M
1-Year Change
55.06%
Ranking
Category
Stock Price
$7.91
Market Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $126.42M, a decrease of -59.51%. That is a compound annual growth rate of -35.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 126.42M | 130.02% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |